share

12H-Benzo[G]Pyrido[2,1-B]Quinazolin-12-One, 1,2,3,4-Tetrahydro-6,11-Dihydroxy- CAS NO 87026-61-7


Unit Price:

CAS No.:87026-61-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

12H-Benzo[G]Pyrido[2,1-B]Quinazolin-12-One, 1,2,3,4-Tetrahydro-6,11-Dihydroxy- is a complex heterocyclic organic compound with the CAS number 87026-61-7. This specialized chemical serves as a crucial advanced pharmaceutical intermediate and a versatile building block in organic synthesis. It is primarily required by research institutions, pharmaceutical R&D labs, and fine chemical manufacturers engaged in developing novel therapeutic agents and high-value specialty chemicals.

Application

  • Pharmaceutical Intermediate: Key precursor in the synthesis of complex drug candidates, particularly those with fused polycyclic structures.
  • Organic Synthesis Building Block: Used in the construction of novel heterocyclic compounds for material science and medicinal chemistry research.
  • Research & Development: Serves as a standard or reference material in academic and industrial R&D for studying quinazoline and pyrido-quinazoline derivatives.
  • Fine Chemical Production: Employed in the manufacture of high-purity, specialty chemicals for advanced applications.
  • Biochemical Research: Potential use as a scaffold or inhibitor in biochemical pathway studies due to its specific fused-ring structure.

Basic Information

Product Name 12H-Benzo[G]Pyrido[2,1-B]Quinazolin-12-One, 1,2,3,4-Tetrahydro-6,11-Dihydroxy-
CAS No. 87026-61-7
Molecular Formula C₁₉H₁₄N₂O₃
Molecular Weight 318.33 g/mol
Synonyms 1,2,3,4-Tetrahydro-6,11-dihydroxy-12H-benzo[g]pyrido[2,1-b]quinazolin-12-one; Benzo[g]pyrido[2,1-b]quinazolin-12(12H)-one, 1,2,3,4-tetrahydro-6,11-dihydroxy-; 6,11-Dihydroxy-1,2,3,4-tetrahydro-12H-benzo[g]pyrido[2,1-b]quinazolin-12-one; Tetrahydro-dihydroxy-benzo[g]pyrido[2,1-b]quinazolinone; BGPQ derivative; 87026-61-7
EINECS Contact for details

Quality Control

Our production of 12H-Benzo[G]Pyrido[2,1-B]Quinazolin-12-One, 1,2,3,4-Tetrahydro-6,11-Dihydroxy- adheres to stringent quality protocols suitable for pharmaceutical intermediate applications. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods. We provide full traceability and Certificates of Analysis (COA) are available upon request, detailing all critical quality attributes to ensure compliance with your specific R&D or production requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item Specification
Appearance Yellow to light brown powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference
Purity (HPLC) ≥ 97.0%
Loss on Drying ≤ 2.0%
Residue on Ignition ≤ 0.5%
Single Unknown Impurity (HPLC) ≤ 1.0%
Total Impurities (HPLC) ≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.